Abstract:To investigate whether myosin is involved in crane-fly primary spermatocyte division, we studied the effects of myosin inhibitors on chromosome movement and on cytokinesis. With respect to chromosome movement, the myosin ATPase inhibitor 2,3-butanedione 2-monoxime (BDM) added during autosomal anaphase reversibly perturbed the movements of all autosomes: autosomes stopped, slowed, or moved backwards during treatment. BDM added before anaphase onset altered chromosome movement less than when BDM was added during anaphase: chromosome movements only rarely were stopped. They often were normal initially and then, if altered at all, were slowed. To confirm that the effects of BDM were due to myosin inhibition, we treated cells with ML-7, a drug that inhibits myosin light chain kinase (MLCK), an enzyme necessary to activate myosin. ML-7 affected anaphase movement only when added in early prometaphase: this treatment prevented chromosome attachment to the spindle. We treated cells with H-7 as a control for possible non-myosin effects of ML-7. H-7, which has a lower affinity than ML-7 for MLCK but a higher affinity than ML-7 for other potential targets, had no effect. These data confirm that the BDM effect is on myosin and indicate that the myosin used for chromosome movement is activated near the start of prometaphase. With respect to cytokinesis, BDM did not block furrow initiation but did block subsequent contraction of the contractile ring. When BDM was added after initiation of the furrow, the contractile ring either stalled or relaxed. ML-7 blocked contractile ring contraction when added at all stages after autosomal anaphase onset, including when added during cytokinesis. H-7 had no effect. These results confirm that the effects of BDM are on myosin and indicate that the myosin used for cytokinesis is activated starting from autosomal anaphase and continuing throughout cytokinesis.

Effects of Myosin Ⅱ Inhibition on NRK Cells Division

The experimental study on the functions of nonmuscle myosin II in dividing mammalian cells

POSSIBLE MECHANISM OF CYTOKINESIS OF MAMMALIAN CELLS IN THE ABSENCE OF MYOSIN Ⅱ

Myosin II motor activity and actin filament cooperatively regulate cytokinesis of mammalian cells

Lamellipodium locomition of the daughter cells facilitates the cytokinesis of NRK cells without Myosin II

The Enzymatic Motor Activity Of Nonmuscle Myosin Ii-B Is Not Critical For Cardiac Myocyte Cytokinesis

Nonmuscle Myosin II Exerts Tension but Does Not Translocate Actin in Vertebrate Cytokinesis

Mechanical Effect of Myosin Ⅱ on Cell Mitosis

Cytokinesis defect in BY-2 cells caused by ATP-competitive kinase inhibitors

The Cleavage Furrow Contractile Stress Analysis in Dividing Nrk Cells

Effects of Polar Cortical Cytoskeleton and Unbalanced Cortical Surface Tension on Intercellular Bridge Thinning During Cytokinesis

Inhibiting nonmuscle myosin II impedes inflammatory infiltration and ameliorates progressive renal disease

Ablation of Nonmuscle Myosin II-B and II-C Reveals a Role for Nonmuscle Myosin II in Cardiac Myocyte Karyokinesis

RhoA-mediated MLC2 Regulates Actin Dynamics for Cytokinesis in Meiosis.

Mklp2 Inhibitior Paprotrain Affects Polar Body Extrusion During Mouse Oocyte Maturation

Effects of anti-myosin drugs on anaphase chromosome movement and cytokinesis in crane-fly primary spermatocytes

Effect of inhibiting cytoskeleton on the mechanical properties of normal rat kidney cells

Progress in research on non-muscle myosin II

Drosophila non-muscle myosin II motor activity determines the rate of tissue folding

Nonmuscle Myosin II Regulation Directs Its Multiple Roles in Cell Migration and Division

Progress in research on non-muscle myosin Ⅱ